Articles tagged with Hepatitis B
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
The European Union has approved a new, inexpensive Hepatitis B test that delivers accurate results within half an hour, enabling doctors to take immediate action on health decisions. The test is expected to make a significant impact in helping to curb the spread of disease and has been developed with support from the Wellcome Trust.
A Mayo Clinic study reveals a 50% decrease in the number of patients listed for a second liver transplant within three years, indicating improved treatment outcomes for some patients with hepatitis B. Researchers found that new medications have improved ability to control hepatitis B recurrence.
Researchers found abnormal forms of apolipoprotein A-I proteins in the livers and blood of infected male mice, but not females. These proteins may provide important markers for tracking hepatitis B progression and help explain the gender disparity in the disease's severity.
A recent study published by Henry Ford Hospital contradicts previous research suggesting hepatitis B infection increases the risk of pancreatic cancer. Age is found to be the only significant predictor of pancreatic cancer in patients infected with hepatitis B.
Progress has been made in vaccinating low-income children on schedule, with significant increases in timely vaccination coverage for varicella and hepatitis B vaccines. However, disparities between low- and high-income children remain, particularly for the DTaP-DTP vaccine.
A systematic review of 33 HBV outbreaks found that administration of drugs using multi-vial compounds and capillary blood sampling with non-disposable devices are the most frequent transmission routes. The study highlights several topical factors, including a high number of outbreaks in dialysis units and associations with multi-vial use.
Two new studies explore ways to clear hepatitis B virus (HBV) and hepatitis C virus (HCV) from patients' bodies. Researchers found that HBV superinfection can lead to clearance of HCV in chronic HCV patients, while interferon-based therapies show promise for treating chronic HBV.
A study by Helmholtz Center researchers reveals that acute hepatitis B infection triggers chronic liver disease through altered T helper cell function. The team identified specific genes and immune mechanisms involved in the development of chronic hepatitis B, shedding light on potential diagnostic markers and treatment options.
The University of Pittsburgh Graduate School of Public Health has been awarded a seven-year $11 million grant to coordinate the Hepatitis B Clinical Research Network, a consortium of 15 US and Canadian institutions. The network will conduct translational research on hepatitis B, aiming to find a lasting cure for the infection.
Global epidemiological studies suggest one-third of chronic hepatitis B infections are acquired during infancy and early childhood. Universal infant immunization is offered in most countries (98%) and has reduced incidence rates in provinces that adopted the program.
The NIH convened a panel to weigh evidence on hepatitis B management, highlighting the need for large studies and representative prospective cohort studies. The panel recommends routine screening for newly arrived immigrants from countries with high hepatitis B prevalence.
Researchers found that chronic hepatitis B patients have higher PD-1 expression on T cells, which impairs HBV-specific T cell responses. In contrast, acute exacerbation of hepatitis B patients have lower PD-1 expression and more intense HBV-specific T cell responses.
A new study has found an association between past hepatitis B infection and pancreatic cancer. Evidence of past hepatitis B exposure was twice as common in patients with pancreatic cancer compared to healthy controls.
A study of 349 children with MS and 2,941 without the disease found that hepatitis B vaccination does not increase multiple sclerosis risk. However, a specific type of vaccine was linked to symptoms in vaccinated children with MS, three or more years after vaccination.
A new nano vaccine for hepatitis B has been developed to address the drawbacks of current vaccines, which require refrigeration and can cause side effects. The vaccine uses a needle-free nasal delivery method and has been shown to be effective in producing strong immune responses in animal studies.
A nested case-control study found that high HBV DNA levels are associated with an increased risk of hepatocellular carcinoma. Patients with higher viral loads have a heightened potential for developing liver cancer, suggesting a potential correlation between viral load and liver cancer development.
Researchers found that T cells in chronically infected patients are triggered to commit suicide due to the presence of a protein called 'Bim'. This discovery provides a new target for developing therapies and vaccines to boost the body's ability to manage Hepatitis B infection.
Data indicate pre-existing lamivudine resistance predisposes patients to higher rates of BARACLUDE resistance. Nucleoside-naive patients experienced a cumulative probability of genotypic resistance of 1.2% through five years.
Researchers have discovered new mechanisms of HBV virulence by studying the effects of X protein on liver cells in transgenic mice. The study found that X protein inhibits liver cell proliferation and affects gene transcription and cholesterol metabolism.
A recent study published in Archives of Pediatrics & Adolescent Medicine found no significant association between hepatitis B vaccination and the development of multiple sclerosis in children. The research involved 143 children who developed MS before age 16, with no increased risk of MS detected within three years of vaccination.
A team of researchers at Stanford University School of Medicine has identified the most cost-effective way to fight treacherous hepatitis B by screening chronically infected individuals. Screening is more effective than vaccination in reducing mortality from hepatitis B, and vaccinating close contacts also provides significant benefits.
Researchers measured the effect of hepatitis B on patients' quality of life, creating a new tool to better assess overall well-being. The study found that psychosocial impact affected many patients more than physical symptoms, underscoring the need for clinicians to consider social and psychological factors in treatment.
A recent study by Johns Hopkins researchers found that entecavir should not be used alone in patients co-infected with HIV, as it can lead to cross-resistance and compromise treatment for the AIDS virus. The study's findings have prompted changes to the drug's labeling and guidelines from governmental agencies.
Infection with hepatitis B causes between 500,000 and 1.2 million deaths worldwide each year, with around 22,000 cases in Europe. A universal childhood vaccination policy is recommended to protect children before they are at risk of infection.
A new survey reveals that chronic hepatitis B patients often misunderstand the nature of their disease and its treatment. Despite being aware of the long-term consequences of the virus, many patients do not comply with their medication regimens, highlighting the need for improved patient education. The study suggests that enhanced pati...
Research suggests sweat can carry hepatitis B virus, potentially transmitting the infection during contact sports. The study found that 13% of Olympic wrestlers had hidden or occult HBV infection and 11% had particles of the virus in their sweat.
A Johns Hopkins study reveals that entecavir can lead to cross-resistance with other antiviral drugs used to treat HIV. The findings have serious implications for co-infected patients who may not be aware of the risks.
A Spanish newspaper launched an HIV/AIDS and hepatitis B information service online, which became extremely popular in both Spain and Latin America. The service answered over 900 queries in its first year of operation.
The study revealed the outer lipid envelope interacts with the capsid shell of hepatitis B virus, which is enormous and nearly 10 times larger than a hemoglobin molecule. The findings may offer new clues on how the virus replicates in vivo.
A randomized controlled study found that pretreating patients with hepatocellular carcinoma (HCC) undergoing chemotherapy with lamivudine significantly reduces the risk of Hepatitis B reactivation and severe hepatitis. The study identified a lower viral load threshold as a better predictor of relapse.
Research suggests that hepatitis B carriers are 1.5 times more likely to have a male child, contributing to the over-representation of males in some Asian countries. In China, hepatitis B accounts for around 75% of the 'missing women', while in other countries it contributes to about 20-45% of the discrepancy.
A study of 1212 children and 446 Italian Air Force recruits found that infant and adolescent immune systems can recall responding to hepatitis B more than 10 years after immunisation. The findings suggest that routine booster doses may not be necessary for long-term protection, even in high-risk populations.
Exposing cells to chloroquine prevents acidification of compartments, allowing proteins to escape and be broken down into smaller pieces displayed to cytolytic T cells. This boosts hepatitis B virus-specific T cell responses in up to 70% of vaccine recipients.
Researchers have identified a protein, heterogeneous ribonucleoprotein K (hnRNP K), that plays a crucial role in the replication of the Hepatitis B virus. This discovery offers new therapeutic opportunities by targeting human proteins involved in viral replication, providing hope for the treatment of chronic Hepatitis B infections.
A seven-year review of liver transplant recipients who received HBV positive and HCV positive organs found patient and graft survival rates comparable to those receiving livers from negative donors. The use of these organs increases the number available for transplantation while maintaining long-term results.
The study found that the newest drug therapy – adefovir – was not cost-effective when taken alone but became very cost-effective when reserved as a second-line agent in people who develop viral resistance for lamivudine. The hybrid treatment strategy of lamivudine and adefovir is also a viable option.
Two studies examine the prevention of type 2 diabetes mellitus, a condition that affects millions of Americans. Researchers found positive lifestyle changes lowered risk among nonsmokers but not smokers. A computer simulation determined the diet-exercise program and metformin therapy were cost-effective options.
Pegylated interferon-alpha shows promise in treating chronic hepatitis B infection, with higher sustained viral response rates compared to monotherapy. The study highlights the importance of hepatitis B virus genotype as a predictor of treatment response.
A recent study using the General Practice Research Database found an association between hepatitis B vaccination and a three-fold increase in MS incidence within three years following vaccination. The study's limitations highlight the need for further research into the potential link between vaccines and autoimmune diseases.
The survey found that despite parents' awareness of hepatitis B, many are unaware of the disease's severity and the availability of a vaccine. The Society for Adolescent Medicine provides guidance to enhance parent-adolescent relationships and offers resources to promote healthy behaviors.
Researchers analyzed 15 years of data on liver transplant recipients with hepatitis B and found significant improvements in 5-year-survival rates from 53% to 76%. Advances in prophylaxis and treatment of recurrent HBV disease likely contributed to these gains.
A study by Brown University researchers found high prevalence of life-threatening and contagious infections among incoming inmates. Nearly 20% tested positive for hepatitis B, highlighting the need for vaccination to prevent transmission upon release into the community.
The temporary suspension of the hepatitis B vaccine at birth due to mercury concerns led to a significant decrease in first-day vaccination coverage. The study found that 11% of children born during the suspension were not vaccinated on their first day, resulting in an excess of 182,000 undervaccinated children by 19 months.
Research has identified improved screening programs for HIV coinfection with chronic hepatitis C, as well as predictive models for inflammation and fibrosis in patients with chronic hepatitis B. These advances aim to improve treatment decisions and quality of life for affected individuals.
A new ribozyme package has been shown to be effective against the hepatitis B virus in an animal model, reducing viral production by over 80% in just three to five days. The treatment uses a specialized cassette that targets and destroys the virus's RNA, making it a promising approach for fighting other viruses as well.
A US CDC study found that 10% of vaccine doses administered to children in 2002 were invalid, resulting from premature vaccination. Invalid doses need to be repeated to ensure adequate protection against disease.
A newly discovered protein causes blood clots in the livers of humans with viral hepatitis and mice exposed to corona virus. Blocking this protein may offer a new approach to treating patients with chronic viral hepatitis and potentially SARS.
Researchers found that fibroleukin is a prothrombinase that contributes to the development of thrombosis in viral hepatitis. The study suggests a potential link between fibroleukin and the progression of viral hepatitis, highlighting the importance of further investigation into this area.
A recent study found that 95% of skin penetration operators believe guidelines are needed, but only half follow them. Tattoo shop operators were more knowledgeable about infection control than others. Barriers to compliance include client perceptions and busy schedules.
A study by Johns Hopkins Medicine found that HIV increases the severity of hepatitis B infections, leading to higher liver disease-related deaths among men with both conditions. The research suggests physicians may see an increase in hepatitis B-related liver disease among the 1 million people living with HIV in the US.
A UC Berkeley study analyzed 27 clinical trials and found that combining Chinese herbal treatments with interferon alfa was 1.5-2 times more effective in reducing viral load than using interferon alfa alone. The most promising results came from patients using a combination of bufotoxin and kurorinone with interferon alfa.
Researchers have found a combination therapy of lamivudine and hepatitis B immune globulin significantly reduces HBV infection recurrence after liver transplant, with one-year and three-year survival rates of 92% and 81%, respectively. This breakthrough treatment offers hope for patients with chronic HBV cirrhosis.
The University of Maryland Medical Center has successfully reduced barriers to kidney transplantation for African-Americans, cutting the median waiting time from 1,335 days to 681 days. The comprehensive program includes patient education and living donation efforts, leading to better graft survival rates.
Researchers found that most hepatitis B virus infections in adult humans are uncomplicated and do not result in large-scale destruction of infected liver cells. A new noncytolytic process targets the virus' ability to reproduce, leaving the liver relatively unscathed.